secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNITED GUARDIAN INC (UG)
CIK:        0000101295
Form:       8-K
Filed at:   2026-05-08T23:59:59+00:00
Accession:  0001171843-26-003193
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

United-Guardian Q1 sales rise 16% to $2.87M; EPS $0.18 vs $0.12 YoY
-------------------------------------------------------------------

- Net income $818,902 ($0.18 per share) vs $560,895 ($0.12) in Q1 2025.
- Pharmaceutical sales up 24% on Renacidin demand; cosmetic ingredient sales up 21%.
- Settlement income from contract manufacturer for Renacidin shutdown in 2023 boosted results.
- President sees momentum from ASI resuming regular purchases and new distribution agreements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/101295/000117184326003193/0001171843-26-003193-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/101295/000117184326003193/f8k_050826.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-003193

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer